Abuse of the patent system by brand-name drug manufacturers is exacerbating the financial burden faced by American patients for their prescription drugs, Lane writes. (George Frey/Getty Images file photo)
OPINION — With the Senate impeachment trial kicking off and partisan tensions running high on several fronts, Americans might be forgiven for thinking that Congress has lost the ability to find common ground. But lately, and despite the proverbial odds, there is a new bipartisan consensus forming on an issue of incredible importance to millions of Americans: prescription drug pricing. Specifically, reforming the U.S. patent system to end abusive practices that are directly contributing to high drug prices.
Across the country, Americans are struggling under the weight of skyrocketing prescription drug costs. It is no secret that affording medicines and treatments is an incredible burden for too many families. On average, Americans are paying considerably more than citizens of other high-income countries for the same exact prescription drugs.